GlassScriptPhysician profile
Andrew Chiou
NPI 1477013738
$2,928.17
in general payments reported to CMS, 2019-2025
20 companies · $1,454 in 2025
The $1,454 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $139 · 2022: $176 · 2023: $454 · 2024: $706 · 2025: $1,454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,430 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,429.97 |
| Education | $182.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $635.60 | 2023-2025 | Onyx Frontier, Resolute Onyx, Ffrangio |
| Boston Scientific Corporation | $502.30 | 2023-2025 | Avvigo Guidance System, General - Vascular Access, Watchman Flx |
| Edwards Lifesciences Corporation | $439.10 | 2025 | Sapien 3 Ultra Resilia, Pascal |
| E.R. Squibb & Sons, L.L.C. | $264.25 | 2021-2022 | |
| Abbott Laboratories | $147.79 | 2023 | Mitraclip |
| Abiomed | $144.12 | 2025 | |
| Kestra Medical Technology Services, INC. | $143.10 | 2025 | Assure Wcd |
| Shockwave Medical, INC | $140.15 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $120.25 | 2025 | Winrevair |
| Lantheus Medical Imaging, INC. | $75.74 | 2024 | |
| Philips North America LLC | $57.53 | 2023-2024 | (Ck4) Mcot |
| Pfizer INC. | $51.20 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $47.98 | 2023 | Arcalyst |
| Novo Nordisk INC | $46.46 | 2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $21.70 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $20.23 | 2023 | Kengreal |
| Kiniksa Pharmaceuticals International, Plc | $20.04 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $18.02 | 2024 | Zio Monitor, Zio Xt Patch |
| Actelion Pharmaceuticals US, INC. | $16.99 | 2025 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $15.62 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Chiou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.